These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8267738)

  • 1. Mediastinal uptake of 131-I in patients with thyroid cancer: may it be referred to normal thymus?
    Bestagno M; Pagliaini R; Maira G; Pizzocaro C
    Eur J Nucl Med; 1993 Jul; 20(7):648. PubMed ID: 8267738
    [No Abstract]   [Full Text] [Related]  

  • 2. Mediastinal images resembling thymus following 131-I treatment for thyroid cancer.
    Montella L; Caraglia M; Abbruzzese A; Soricelli A; Caputi M; Squame G; Salvatore M; Del Prete S; Palmieri G
    Monaldi Arch Chest Dis; 2005 Jun; 63(2):114-7. PubMed ID: 16128228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymic uptake after high-dose I-131 treatment in patients with differentiated thyroid carcinoma: a brief review of possible causes and management.
    Arce MB; Molina TC; Hernández TM; de la Cinta Calvo Morón M; Herrero CH; De La Riva Pérez PA; Montaño JC
    Endocrinol Nutr; 2015 Jan; 62(1):19-23. PubMed ID: 25160708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SPECT/CT identification of post-radioactive iodine treatment false-positive uptake in a simple renal cyst.
    Thust S; Fernando R; Barwick T; Mohan H; Clarke SE
    Thyroid; 2009 Jan; 19(1):75-6. PubMed ID: 19119982
    [No Abstract]   [Full Text] [Related]  

  • 5. Exercise-induced radio-iodine accumulation in scalp and hair during admission of 131I therapy for thyroid cancer.
    Zakavi SR; Kakhki VD
    Thyroid; 2006 Nov; 16(11):1185-6. PubMed ID: 17123349
    [No Abstract]   [Full Text] [Related]  

  • 6. Patterns of relapse following radiotherapy for differentiated thyroid cancer: implication for target volume delineation.
    Azrif M; Slevin NJ; Sykes AJ; Swindell R; Yap BK
    Radiother Oncol; 2008 Oct; 89(1):105-13. PubMed ID: 18579244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iodine concentration by the thymus in thyroid carcinoma.
    Vermiglio F; Baudin E; Travagli JP; Caillou B; Fragu P; Ricard M; Schlumberger M
    J Nucl Med; 1996 Nov; 37(11):1830-1. PubMed ID: 8917186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should 'low-risk' thyroid cancer patients with residual thyroglobulin be re-treated with iodine 131?
    Hindié E; Zanotti-Fregonara P; Duron F; Keller I; Bouchard P; Devaux JY
    Clin Endocrinol (Oxf); 2007 Mar; 66(3):329-34. PubMed ID: 17302864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mediastinal radioiodine uptake due to hiatal hernia: a false-positive reason in 131I scan.
    Ceylan Gunay E; Erdogan A
    Rev Esp Med Nucl; 2010; 29(2):95. PubMed ID: 19954864
    [No Abstract]   [Full Text] [Related]  

  • 10. [The use of 131I in the combined modality therapy of highly differentiated cancer of the thyroid gland].
    Baranauskas ZL; Mamontov VV; Valutskas KK
    Med Radiol (Mosk); 1989 Oct; 34(10):31-4. PubMed ID: 2811625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visualization of the thymus with therapeutic doses of radioiodine in patients with thyroid cancer.
    Michigishi T; Mizukami Y; Shuke N; Yokoyama K; Noguchi M; Watanabe Y; Matsui O; Aburano T; Tonami N; Hisada K
    Eur J Nucl Med; 1993 Jan; 20(1):75-9. PubMed ID: 8267685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should high hTg levels in the absence of iodine uptake be treated?
    Britton KE; Foley RR; Chew SL
    Eur J Nucl Med Mol Imaging; 2003 May; 30(5):794-5. PubMed ID: 12616324
    [No Abstract]   [Full Text] [Related]  

  • 13. Quantitative approach to radioiodine ablation of thyroid remnants following surgery for thyroid cancer.
    Hadjieva T
    Radiobiol Radiother (Berl); 1985; 26(6):819-23. PubMed ID: 4095270
    [No Abstract]   [Full Text] [Related]  

  • 14. Presentation and practical management to optimize radioiodine treatment of well differentiated thyroid cancer: ablation of thyroid remnants with radioiodine.
    Janisch A; Altenbrunn HJ; Markwardt J
    Radiobiol Radiother (Berl); 1987; 28(5):707-10. PubMed ID: 3441634
    [No Abstract]   [Full Text] [Related]  

  • 15. The success rate of I-131 ablation in differentiated thyroid cancer: comparison of uptake-related and fixed-dose strategies.
    Verkooijen RB; Verburg FA; van Isselt JW; Lips CJ; Smit JW; Stokkel MP
    Eur J Endocrinol; 2008 Sep; 159(3):301-7. PubMed ID: 18567668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors influencing radioiodine uptake after thyroid cancer surgery.
    Bai JB; Shakerian R; Westcott JD; Lichtenstein M; Miller JA
    ANZ J Surg; 2015; 85(7-8):572-7. PubMed ID: 23964714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An analysis of "ablation of thyroid remnants" with I-131 in 511 patients from 1947-1984: experience at University of Michigan.
    Beierwaltes WH; Rabbani R; Dmuchowski C; Lloyd RV; Eyre P; Mallette S
    J Nucl Med; 1984 Dec; 25(12):1287-93. PubMed ID: 6502251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hemorheologic monitoring of thyroid cancer patients treated with mega-radioiodine therapy].
    Költringer P; Eber O; Lind P; Langsteger W; Klima K
    Radiobiol Radiother (Berl); 1988; 29(2):245-7. PubMed ID: 3399666
    [No Abstract]   [Full Text] [Related]  

  • 19. Esophageal diverticulum presenting as metastatic thyroid mass on iodine-131 scintigraphy.
    Rashid K; Johns W; Chasse K; Walker M; Gupta SM
    Clin Nucl Med; 2006 Jul; 31(7):405-8. PubMed ID: 16785810
    [No Abstract]   [Full Text] [Related]  

  • 20. Thymic uptake of iodine-131 in the anterior mediastinum.
    Veronikis IE; Simkin P; Braverman LE
    J Nucl Med; 1996 Jun; 37(6):991-2. PubMed ID: 8683329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.